Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1231)

CONNECTED TRANSACTION

ASSIGNMENT AND NOVATION AGREEMENT IN RELATION TO

THE LONG TERM HEMATITE SUPPLY AGREEMENT

COMPLETION

Reference is made to the announcement of Newton Resources Ltd (the " Company") dated 31 May 2019 and the circular of the Company dated 8 July 2019 (the " Circular") in relation to, among others, the connected transaction in respect of the Assignment and Novation Agreement. Unless the context otherwise requires, capitalised terms used herein shall have the same meanings as those defined in the Circular.

The Board is pleased to announce that all conditions precedent in respect of the Assignment and Novation Agreement have been fulfilled and accordingly the Completion took place on 7 August 2019 in accordance with the terms and conditions of the Assignment and Novation Agreement.

By order of the Board

Newton Resources Ltd

Chong Tin Lung, Benny

Chairman and executive Director

Hong Kong, 7 August 2019

As at the date of this announcement, the executive Directors are Mr. Chong Tin Lung, Benny, Mr. Li Changfa and Mr. Luk Yue Kan; the non-executive Director is Mr. Wu Wai Leung, Danny; and the independent non-executive Directors are Mr. Tsui King Fai, Mr. Lee Kwan Hung and Mr. Shin Yick, Fabian.

Attachments

  • Original document
  • Permalink

Disclaimer

Newton Resources Ltd. published this content on 07 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 August 2019 10:04:05 UTC